Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Relay Therapeutics (RLAY)
NASDAQ:RLAY
Relay Therapeutics (RLAY) Ownership - Who Owns Relay Therapeutics?
280 Followers
Relay Therapeutics (RLAY) Ownership Overview
34.38% Insiders
27.15% Mutual Funds
16.73% Other Institutional Investors
21.74% Public Companies and
Individual Investors
The ownership structure of Relay Therapeutics (RLAY) stock is a mix of institutional, retail and individual investors. Approximately 43.88% of the company’s stock is owned by Institutional Investors, 34.38% is owned by Insiders and 21.74% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 29, 2024 | Brian Adams Clo | Sold | $2680 |
| Mar 29, 2024 | Donald A Bergstrom President, R&d | Sold | $5891 |
| Mar 29, 2024 | Peter Rahmer Chief Corporate Development Officer | Sold | $2295 |
| Mar 29, 2024 | Sold | $2680 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $177646 | |
| Dec 31, 2023 | Bought | $352595 | |
| Dec 31, 2023 | Sold | $755352 | |
| Dec 31, 2023 | Bought | $3072902 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,406,140 | Institution | 8.70% | 69,691,515 | |
| 9,643,411 | Institution | 7.35% | 58,921,241 | |
| 4,531,506 | Institution | 3.45% | 27,687,502 | |
| 3,763,616 | Institution | 2.87% | 22,995,694 | |
| 3,101,142 | Institution | 2.36% | 18,947,978 | |
| 2,573,330 | Institution | 1.96% | 15,723,046 | |
| 2,469,080 | Institution | 1.88% | 15,086,079 | |
| 1,943,097 | Institution | 1.48% | 11,872,323 | |
| 1,773,894 | Institution | 1.35% | 10,838,492 | |
| 1,160,117 | Institution | 0.88% | 7,088,315 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,643,411 | Institution | 7.35% | 58,921,241 | |
| 3,101,142 | Institution | 2.36% | 18,947,978 | |
| 2,573,330 | Institution | 1.96% | 15,723,046 | |
| 2,469,080 | Institution | 1.88% | 15,086,079 | |
| 1,773,894 | Institution | 1.35% | 10,838,492 | |
| 1,121,009 | Institution | 0.85% | 6,849,365 | |
| 996,356 | Institution | 0.76% | 6,087,735 | |
| 911,192 | Institution | 0.69% | 5,567,383 | |
| 878,903 | Institution | 0.67% | 5,370,097 | |
| 865,767 | Institution | 0.66% | 5,289,836 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,319,484 | Institution | 3.29% | 35,851,717 | |
| 3,182,699 | Institution | 2.43% | 26,416,402 | |
| 3,644,520 | Institution | 2.78% | 22,632,469 | |
| 1,799,336 | Institution | 1.37% | 14,934,489 | |
| 2,250,903 | Institution | 1.72% | 13,753,017 | |
| 1,381,156 | Institution | 1.05% | 11,463,595 | |
| 889,559 | Institution | 0.68% | 5,435,205 | |
| 681,390 | Institution | 0.52% | 4,163,293 | |
| 352,627 | Institution | 0.27% | 2,926,804 | |
| 444,783 | Institution | 0.34% | 2,762,102 |
FAQ
Who Owns Relay Therapeutics (RLAY)?
According to the latest TipRanks data, approximately 16.73% of the company's stock is held by institutional investors, 34.38% is held by insiders, and 21.74% is held by retail investors.
What percentage of Relay Therapeutics (RLAY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 16.73% of Relay Therapeutics (RLAY) stock is held by institutional investors.
What percentage of Relay Therapeutics (RLAY) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.74% of Relay Therapeutics (RLAY) stock is held by retail investors.
Who owns the most shares of Relay Therapeutics (RLAY)?
Vanguard owns the most shares of Relay Therapeutics (RLAY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.